{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T14:23:36Z","timestamp":1768746216263,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2369-15-157","type":"journal-article","created":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T03:11:53Z","timestamp":1412133113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A rare association between Fabry\u2019s disease and granulomatosis with polyangiitis: a potential pathogenic link"],"prefix":"10.1186","volume":"15","author":[{"given":"Hironari","family":"Hanaoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konosuke","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,1]]},"reference":[{"key":"847_CR1","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","volume":"276","author":"RO Brady","year":"1967","unstructured":"Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L: Enzymatic defect in Fabry\u2019s disease: ceramidetrihexosidase deficiency. N Engl J Med. 1967, 276: 1163-1167. 10.1056\/NEJM196705252762101.","journal-title":"N Engl J Med"},{"key":"847_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1399-0004.1991.tb03018.x","volume":"39","author":"Y Nagano","year":"1991","unstructured":"Nagano Y, Nakashima H, Fukuhara Y, Shimmoto M, Oshima A, Ikari Y, Mori Y, Sakuraba H, Suzuki Y: Hypertrophic cardiomyopathy in late-onset variant of Fabry\u2019s disease with high residual activity of alpha-galactosidase A. Clin Genet. 1991, 39: 233-237.","journal-title":"Clin Genet"},{"key":"847_CR3","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"R Schiffmann","year":"2001","unstructured":"Schiffmann R, Kopp JB, Austin HA, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO: Enzyme replacement therapy in Fabry disease: A randomized controlled trial. JAMA. 2001, 285: 2743-2749. 10.1001\/jama.285.21.2743.","journal-title":"JAMA"},{"key":"847_CR4","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1136\/jmg.38.11.750","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH: Anderson\u2013Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet. 2001, 38: 750-760. 10.1136\/jmg.38.11.750.","journal-title":"J Med Genet"},{"key":"847_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jmg.38.11.769","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH: Anderson\u2013Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet. 2001, 38: 769-775. 10.1136\/jmg.38.11.769.","journal-title":"J Med Genet"},{"key":"847_CR6","doi-asserted-by":"publisher","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","volume":"116","author":"GS Hoffman","year":"1992","unstructured":"Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS: Wegener\u2019s granulomatosis: analysis of 158 patients. Ann Intern Med. 1992, 116: 488-498. 10.7326\/0003-4819-116-6-488.","journal-title":"Ann Intern Med"},{"key":"847_CR7","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.rdc.2010.04.002","volume":"36","author":"E Ntatsaki","year":"2010","unstructured":"Ntatsaki E, Watts RA, Scott DG: Epidemiology of ANCA-associated vasculitis. Rheum Dis Clin North Am. 2010, 36: 447-461. 10.1016\/j.rdc.2010.04.002.","journal-title":"Rheum Dis Clin North Am"},{"key":"847_CR8","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/art.24544","volume":"61","author":"RA Watts","year":"2009","unstructured":"Watts RA, Al-Taiar A, Scott DG, Macgregor AJ: Prevalence and incidence of Wegener\u2019s granulomatosis in the UK general practice research database. Arthritis Rheum. 2009, 61: 1412-1416. 10.1002\/art.24544.","journal-title":"Arthritis Rheum"},{"key":"847_CR9","first-page":"73","volume":"55","author":"HK Singh","year":"2001","unstructured":"Singh HK, Nickeleit V, Kriegsmann J, Harris AA, Jennette JC, Mihatsch MJ: Coexistene of Fabry\u2019s disease and necrotizing and crescentic glomerulonephritis. Clin Nephrol. 2001, 55: 73-79.","journal-title":"Clin Nephrol"},{"key":"847_CR10","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1159\/000063287","volume":"92","author":"K Shimazu","year":"2002","unstructured":"Shimazu K, Tomiyoshi Y, Aoki S, Sakemi T, Sugihara H: Crescentic glomerulonephritis in a patient with heterozygous Fabry\u2019s disease. Nephron. 2002, 92: 456-458. 10.1159\/000063287.","journal-title":"Nephron"},{"key":"847_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/0161-5890(78)90130-X","volume":"15","author":"NM Hamers","year":"1978","unstructured":"Hamers NM, Donker-Koopman WE, Coulon-Morelec MJ, Dupouey P, Tager JM: Characterization of antibodies against ceramide trihexoside and globoside. Immunochemistry. 1978, 15: 353-358. 10.1016\/0161-5890(78)90130-X.","journal-title":"Immunochemistry"},{"key":"847_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1124\/jpet.111.181560","volume":"339","author":"WC Lin","year":"2011","unstructured":"Lin WC, Lin CF, Chen CL, Chen CW, Lin YS: Inhibition of neutrophil apoptosis via sphingolipid signaling in acute lung injury. J Pharmacol Exp Ther. 2011, 339: 45-53. 10.1124\/jpet.111.181560.","journal-title":"J Pharmacol Exp Ther"},{"key":"847_CR13","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1681\/ASN.2005101048","volume":"5","author":"JC Jennette","year":"2006","unstructured":"Jennette JC, Xiao H, Falk RJ: Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol. 2006, 5: 1235-1242.","journal-title":"J Am Soc Nephrol"},{"key":"847_CR14","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1046\/j.1523-1755.2000.00080.x","volume":"57","author":"CF Franssen","year":"2000","unstructured":"Franssen CF, Stegeman CA, Kallenberg CG, Gans RO, De Jong PE, Hoorntje SJ, Tervaert JW: Antiproteinase 3 and antimyeloperoxidase associated vasculitis. Kidney Int. 2000, 57: 2195-2206. 10.1046\/j.1523-1755.2000.00080.x.","journal-title":"Kidney Int"},{"key":"847_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000096960","volume":"105","author":"P Van Paassena","year":"2007","unstructured":"Van Paassena P, Tervaerta JW, Heeringab P: Mechanisms of vasculitis. how pauci-immune is ANCA-associated renal vasculitis?. Nephron Exp Nephrol. 2007, 105: 10-16. 10.1159\/000096960.","journal-title":"Nephron Exp Nephrol"},{"key":"847_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","volume":"64","author":"S Nakao","year":"2003","unstructured":"Nakao S, Kodama C, Takenaka T, Tanaka A, Yasumoto Y, Yoshida A, Kanzaki T, Enriquez AL, Eng CM, Tanaka H, Tei C, Desnick RJ: Fabry\u2019s disease: Detection of underdiagnosed hemodialysis patients and identification of a \"renal variant\" phenotype. Kidney Int. 2003, 64: 801-807. 10.1046\/j.1523-1755.2003.00160.x.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-15-157.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-15-157\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-15-157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-15-157.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T04:27:43Z","timestamp":1548217663000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-15-157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["847"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-15-157","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,1]]},"assertion":[{"value":"11 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"157"}}